logo
ENTITY
I-Mab

I-Mab (IMAB US)

56
Analysis
Health Care • China
I-Mab operates as a clinical stage biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of novel biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab conducts business in China.
more
Company Event • 15 Mar 2025 04:00 • Upcoming
Add To Calendar

Q4 2024

Company Event • 14 Nov 2024 20:00 • Upcoming
Add To Calendar

Q3 2024

Company Event • 28 Aug 2024 20:00 • Latest

H1 2024

Company Event • 28 Aug 2024 19:00 • Upcoming
Add To Calendar

Corporate Presentation

Company Event • 14 Mar 2024 20:00 • Upcoming
Add To Calendar

H2 2023

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x